Literature DB >> 31475194

Quantitative gait analysis for laser cue in Parkinson's disease patients with freezing of gait.

Liang Tang1, Wei Xu1, Zhikun Li1, Yu Chen1, Haojie Chen1, Ronghua Yu1, Xiaodong Zhu1, Dongyun Gu2,3,4.   

Abstract

BACKGROUND: The aim of this study was to investigate the gait spatiotemporal, kinematic, and kinetic changes of Parkinson's disease (PD) patient with freezing of gait (FOG) under the laser cue (LC). Such an approach may provide greater insight into the effects of LC on gait.
METHODS: Thirty-four PD with FOG (PD + FOG) and 32 healthy controls (HC) were tested in gait laboratory. Patients were tested at their usual self-selected speed in no laser cue (NC) first and then under LC condition. Sagittal plane kinematic and kinetic parameters of the lower-limb joints (hip, knee, and ankle joints) as well as spatiotemporal parameters (velocity, cadence, stride length, single and double support time), were measured. Spatiotemporal parameters and kinematic were submitted to one-way analysis of variance (ANOVA) to explore difference among NC, LC, and HC. Covariance analysis was used to compare kinetic parameters.
RESULTS: For PD + FOG, spatiotemporal parameters (stride length, velocity, and cadence) were significantly improved in LC (1.06±0.18, 1.01±0.19, 120±13.26, respectively) compared with NC (0.93±0.20, 0.87±0.17, 131±14.75) (P=0.027, 0.045, 0.035, respectively), and close to HC (1.1±0.12, 1.12±0.13, 116±9.37) (P=0.594, 0.276, 0.084, respectively). In kinematics, LC could significantly ameliorate the amplitude of maximal dorsiflexion in ankle (35.1±3.8), extension in stance in knee (16.8±4.3) and hip (4.43±5.1), as well as the range of motion (ROM) in ankle (33.15±6.1) and hip joints (38.6±3.3). In kinetics, LC also markedly improved power generation in ankle (2.03±1.52) and hip joints (1.08±0.48) and power absorption in pre-swing phase in knee joint (-1.68±0.29) compared with NC (1.37±1.13, 0.899±0.43, -1.31±0.27, respectively).
CONCLUSIONS: LC significantly improves gait performance in spatiotemporal parameters as well as kinematics and kinetics performance in ankle and hip joints. LC may be promising when applied as an optional technique in the rehabilitation training in PD + FOG.

Entities:  

Keywords:  Parkinson’s disease (PD); freezing of gait (FOG); gait analysis; visual cue, laser

Year:  2019        PMID: 31475194      PMCID: PMC6694277          DOI: 10.21037/atm.2019.05.87

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  26 in total

1.  Botulinum toxin type B for gait freezing in Parkinson's disease.

Authors:  Hubert H Fernandez; Margaret C Lannon; Martha E Trieschmann; Joseph H Friedman
Journal:  Med Sci Monit       Date:  2004-06-29

2.  Gait freezing in Parkinson's disease and the stride length sequence effect interaction.

Authors:  Rachel Chee; Anna Murphy; Mary Danoudis; Nellie Georgiou-Karistianis; Robert Iansek
Journal:  Brain       Date:  2009-05-11       Impact factor: 13.501

3.  Visual control of locomotion in Parkinson's disease.

Authors:  J P Azulay; S Mesure; B Amblard; O Blin; I Sangla; J Pouget
Journal:  Brain       Date:  1999-01       Impact factor: 13.501

4.  Stride length regulation in Parkinson's disease: the use of extrinsic, visual cues.

Authors:  G N Lewis; W D Byblow; S E Walt
Journal:  Brain       Date:  2000-10       Impact factor: 13.501

5.  Quantitative gait analysis in Parkinson's disease: comparison with a healthy control group.

Authors:  Olumide Sofuwa; Alice Nieuwboer; Kaat Desloovere; Anne-Marie Willems; Fabienne Chavret; Ilse Jonkers
Journal:  Arch Phys Med Rehabil       Date:  2005-05       Impact factor: 3.966

6.  Effects of long-term gait training using visual cues in an individual with Parkinson disease.

Authors:  Ben Sidaway; Jennifer Anderson; Garth Danielson; Lucas Martin; Garth Smith
Journal:  Phys Ther       Date:  2006-02

7.  "On" freezing in Parkinson's disease: resistance to visual cue walking devices.

Authors:  K Kompoliti; C G Goetz; S Leurgans; M Morrissey; I M Siegel
Journal:  Mov Disord       Date:  2000-03       Impact factor: 10.338

8.  What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study.

Authors:  A J Hughes; Y Ben-Shlomo; S E Daniel; A J Lees
Journal:  Neurology       Date:  1992-06       Impact factor: 9.910

9.  Three-dimensional gait biomechanics in Parkinson's disease: evidence for a centrally mediated amplitude regulation disorder.

Authors:  Meg Morris; Robert Iansek; Jennifer McGinley; Thomas Matyas; Frances Huxham
Journal:  Mov Disord       Date:  2005-01       Impact factor: 10.338

10.  Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition.

Authors:  J B Rowe; L Hughes; B C P Ghosh; D Eckstein; C H Williams-Gray; S Fallon; R A Barker; A M Owen
Journal:  Brain       Date:  2008-06-24       Impact factor: 13.501

View more
  2 in total

Review 1.  Therapeutic Devices for Motor Symptoms in Parkinson's Disease: Current Progress and a Systematic Review of Recent Randomized Controlled Trials.

Authors:  Joji Fujikawa; Ryoma Morigaki; Nobuaki Yamamoto; Teruo Oda; Hiroshi Nakanishi; Yuishin Izumi; Yasushi Takagi
Journal:  Front Aging Neurosci       Date:  2022-03-29       Impact factor: 5.702

Review 2.  Detection and assessment of Parkinson's disease based on gait analysis: A survey.

Authors:  Yao Guo; Jianxin Yang; Yuxuan Liu; Xun Chen; Guang-Zhong Yang
Journal:  Front Aging Neurosci       Date:  2022-08-03       Impact factor: 5.702

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.